A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Abroad (travel likely)RecruitingPHASE3

Conditions

Alzheimer Disease · Dementia · Plaque, Amyloid

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Banner Alzheimer's Institute, Phoenix, Arizona, United States

    Study coordinator · 602-839-6900
    Contact: Principal Investigator (Po-Heng Tsai)
  • Care Access - Huntington Beach, Huntington Beach, California, United States

    Study coordinator · 714-378-2440
    Contact: Principal Investigator (Christine Thai)
  • Irvine Clinical Research, Irvine, California, United States

    Study coordinator · 949-753-1663
    Contact: Principal Investigator (Elly Lee)
  • Healthy Brain Clinic, Long Beach, California, United States

    Study coordinator · 562-606-5999
    Contact: Principal Investigator (Dung Trinh)
  • Artemis Institute for Clinical Research, Riverside, California, United States

    Study coordinator · 951-374-1190
    Contact: Principal Investigator (Jack Vu)
  • Clinical Trials Research, Sacramento, California, United States

    Study coordinator · 916-434-8230
    Contact: Principal Investigator (Jeffrey Wayne)
  • Artemis Institute for Clinical Research, San Diego, California, United States

    Study coordinator · 858-278-3647
    Contact: Principal Investigator (Eric Chavez)
  • Syrentis Clinical Research, Santa Ana, California, United States

    Study coordinator · 714-542-3008
    Contact: Principal Investigator (John Duffy)
  • Providence Medical Foundation, Santa Rosa, California, United States

    Study coordinator · 707-521-3830
    Contact: Principal Investigator (Allan Bernstein)
  • Infectious Disease Doctors Medical Group, APC, Walnut Creek, California, United States

    Study coordinator · 925-947-2334
    Contact: Principal Investigator (Bhavna Malik)
  • VIN - Aventura, Aventura, Florida, United States

    Study coordinator · 305-933-5993
    Contact: Principal Investigator (Jonathan Cross)
  • Bradenton Research Center, Inc., Bradenton, Florida, United States

    Study coordinator · 941-708-0005
    Contact: Principal Investigator (Eric Folkens)
  • Finlay Medical Research, Greenacres City, Florida, United States

    Study coordinator · 561-766-2181
    Contact: Principal Investigator (Jorge Calle Medina)
  • Jacksonville Center for Clinical Research, Jacksonville, Florida, United States

    Study coordinator · 904-730-0101
    Contact: Principal Investigator (Steven Toenjes)
  • K2 Medical Research ORLANDO, Maitland, Florida, United States

    Study coordinator · 407-500-5252
    Contact: Principal Investigator (Brandon Lenox)
  • Merritt Island Medical Research, LLC, Merritt Island, Florida, United States

    Contact: Principal Investigator (David Kirk)
  • Finlay Medical Research, Miami, Florida, United States

    Contact: Principal Investigator (Lilia Rodriguez Ables)
  • VIN-Andrew Lerman, Miami, Florida, United States

    Study coordinator · 786-655-8010
    Contact: Principal Investigator (Andrew Lerman)
  • Indago Research & Health Center, Inc, Miami Lakes, Florida, United States

    Study coordinator · 305-825-6588
    Contact: Principal Investigator (Jose Cardona)
  • Adult Medicine of Lake County, Inc., Mt. Dora, Florida, United States

    Study coordinator · 352-383-8222
    Contact: Principal Investigator (Shirley Nagel)
  • Suncoast Clinical Research, Inc., New Port Richey, Florida, United States

    Study coordinator · 727-849-4131
    Contact: Principal Investigator (Cathy Barnes)
  • Charter Research - Orlando, Orlando, Florida, United States

    Study coordinator · 407-337-3000
    Contact: Principal Investigator (Edgardo Rivera-Rivera)
  • Headlands Research Orlando, Orlando, Florida, United States

    Study coordinator · 407-705-3471
    Contact: Principal Investigator (Uzma Khan)
  • Emerald Coast Neurology - Airport Boulevard, Pensacola, Florida, United States

    Study coordinator · 850-438-1136
    Contact: Principal Investigator (David Bear)
  • Progressive Medical Research, Port Orange, Florida, United States

    Study coordinator · 386-304-7070
    Contact: Principal Investigator (Alexander White)
  • Care Access - Tampa, Tampa, Florida, United States

    Study coordinator · 877-791-0656
    Contact: Principal Investigator (Brad Lipson)
  • K2 Medical Research - Tampa, Tampa, Florida, United States

    Study coordinator · 813-800-5252
    Contact: Principal Investigator (Kelley Wilson)
  • Charter Research - The Villages, The Villages, Florida, United States

    Study coordinator · 352-441-2000
    Contact: Principal Investigator (Jeffrey Norton)
  • Conquest Research, Winter Park, Florida, United States

    Study coordinator · 407-916-0060
    Contact: Principal Investigator (Rekha Gandhi)
  • Center for Advanced Research & Education, Gainesville, Georgia, United States

    Study coordinator · 770-534-5154
    Contact: Principal Investigator (Angela Ritter)
  • North Georgia Clinical Research, Woodstock, Georgia, United States

    Study coordinator · 678-494-5735
    Contact: Principal Investigator (Bram Wieskopf)
  • Northwest Clinical Trials, Boise, Idaho, United States

    Study coordinator · 208-685-0600
    Contact: Principal Investigator (Brock McConnehey)
  • Great Lakes Clinical Trials - Andersonville, Chicago, Illinois, United States

    Study coordinator · 773-275-3500
    Contact: Principal Investigator (Jeffrey Ross)
  • Care Access - South Indianapolis, Indianapolis, Indiana, United States

    Study coordinator · 877-791-0656
    Contact: Principal Investigator (Gigi Lefebvre)
  • Josephson Wallack Munshower Neurology, PC, Indianapolis, Indiana, United States

    Study coordinator · 317-537-6099
    Contact: Principal Investigator (Kristi George)
  • Covenant Medical Center, Waterloo, Iowa, United States

    Study coordinator · 319-272-2112
    Contact: Principal Investigator (NICHOLAS GOETSCH)
  • Care Access - Lake Charles (Bayou Pines), Lake Charles, Louisiana, United States

    Study coordinator · 337-602-6642
    Contact: Principal Investigator (Jason Morris)
  • Boston Center for Memory, Newton, Massachusetts, United States

    Study coordinator · 617-699-6927
    Contact: Principal Investigator (Paul Solomon)
  • MedVadis Research Corporation, Waltham, Massachusetts, United States

    Study coordinator · 617-744-1310
    Contact: Principal Investigator (David DiBenedetto)
  • Revival Research Institute, LLC, Southfield, Michigan, United States

    Study coordinator · 586-276-7453
    Contact: Principal Investigator (Abdulhassan Saad)
  • Citizens Memorial Hospital District, Bolivar, Missouri, United States

    Study coordinator · 417-328-7781
    Contact: Principal Investigator (Curtis Schreiber)
  • Vector Clinical Trials, Las Vegas, Nevada, United States

    Study coordinator · 702-750-000
    Contact: Principal Investigator (Bharat Mocherla)
  • The Cognitive and Research Center of New Jersey, Springfield, New Jersey, United States

    Contact: Principal Investigator (Raminder Parihar)
  • Monroe Biomedical Research, Monroe, North Carolina, United States

    Study coordinator · 704-283-7359
    Contact: Principal Investigator (Awawu Igbinadolor)
  • NDx Clinical Research, Inc., Dayton, Ohio, United States

    Study coordinator · 937-224-8200
    Contact: Principal Investigator (Joel Vandersluis)
  • Care Access - Lima, Lima, Ohio, United States

    Study coordinator · 877-791-0656
    Contact: Principal Investigator (Gigi Lefebvre)
  • Senior Adults Specialty Research, Austin, Texas, United States

    Study coordinator · 512-407-8628
    Contact: Principal Investigator (John Bertelson)
  • Gadolin Research, Beaumont, Texas, United States

    Study coordinator · 409-331-6040
    Contact: Principal Investigator (Joseph Oommen)
  • The University of Texas Health Science Center at Houston, Houston, Texas, United States

    Study coordinator · 713-486-0536
    Contact: Principal Investigator (David Hunter)
  • Consano Clinical Research, LLC, Shavano Park, Texas, United States

    Study coordinator · 210-545-4900
    Contact: Principal Investigator (Michelle Welch)
  • Northwest Clinical Research Center, Bellevue, Washington, United States

    Contact: Principal Investigator (Jeena Vaid)
  • Universal Research Group, Tacoma, Washington, United States

    Study coordinator · 253-882-1070
    Contact: Principal Investigator (Sabrina Benjamin)
  • Tokyo-Eki Center-building Clinic, Chūōku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Arihiro Kiyosue)
  • P-One Clinic, Hachiōji, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Kenichi Furihata)
  • National Center for Geriatrics and Gerontology, Ōbu, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (MASASHI TSUJIMOTO)
  • Samoncho Clinic, Shinjuku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Takahiro Yokoyama)
  • Yotsuya Internal Medicine Clinic, Shinjyuku, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (takahiro yokoyama)
  • Tokyo Metropolitan Institute for Geriatrics and Gerontology, tabashi City, Japan

    Study coordinator · 81120023812
    Contact: Principal Investigator (Atsushi Iwata)
  • SCB Research Center, Bayamón, Puerto Rico

    Study coordinator · (787) 798-4592
    Contact: Principal Investigator (William Julio)
Study leads
  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company